1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Sephb4-Hsa: new trials by email Literature Review of Sephb4-Hsa trials Research Report on Sephb4-Hsa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent Azacitidine, Decitabine, Laboratory Biomarker Analysis - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | Terminated | University of Southern California | 7 | 2017-04-20 | 2026-06-08 |
Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1)
University of Southern California (1)
United States (1)
P30CA014089 (1)